Arquer Diagnostics

#ArquerDiagnostics is leading the way in non-invasive tests for diagnosing and monitoring cancer.
#ADXBLADDER is a game-changing urine test for #bladdercancer

[Arquer Diagnostics @ArquerDx]

Well done @QEHResearch @GeordieGynae @WendyMc65962923 and the Team! Trials can only happen with the strong support of brilliant NHS individuals and patients' trust; let's deliver this much needed innovation to women around the world, together!

[Gateshead Research and Development @QEHResearch]

Brilliant work from our Gynae research team 👏 👏

[Arquer Diagnostics @ArquerDx]

@drdonsdizon @agz_eriksson #equity in access is something we hope to ensure with our cost-effective technology currently in clinical trial. As an SME we hope to be able to get enough support to ensure all patients will be able to access it!

[Arquer Diagnostics @ArquerDx]

This is why our current European Uterine Clinical Trial on #uterinecancer #diagnostic urinary biomarker could be so fundamental for millions of #women around the world.
#endometrialcancer #gyncancer #gyncsm #womenhealth @agz_eriksson

[Ane Gerda Z Eriksson MD PhD @agz_eriksson]

📈#UterineCancer projected to become 3rd most common #cancer in #women
#EndometrialCancer #GynCancer #gyncsm #womenshealth
⁦@nytimes⁩ ⁦@drcarolbrownMSK⁩ ⁦@KemiDoll⁩ ⁦@ShannonWestin⁩ ⁦@TeamEndo_MSK⁩ ⁦@Oslounivsykehus⁩ https://t.co/T8E0uvauAI

[Arquer Diagnostics @ArquerDx]

Great to see narrative around pts empowerment getting stronger. Our #Clinicaltrial on a novel urine test for the detection of #endometrialcancer is now open in 9 UK centres and pts have embraced the opportunity to be part of #innovation in #uterinecancer
@WombCancerUK @ucan2020

[Patient Chat @patientchat]

Don't miss our Empowered #PatientChat, "Being a Decision-Maker in Clinical Trial Participation" on Twitter Spaces with @Srotberg15 and @KDRichardson924 on Friday, June 17th @ 10 AM PT/ 1 PM ET.

https://t.co/3IphavcM1X

[Arquer Diagnostics @ArquerDx]

Great work by the @NHSBartsHealth Team.
#haematuria pathway improvements on the way thanks to the commitment and vision of all involved

[Arquer Diagnostics @ArquerDx]

If you are attending St Marys Hospital, Manchester for investigations for post-menopausal bleeding and would like more information, please contact us on [phone]
@manchesterunive @StMarysU @ucan2020 @EndometrialCanc

[Arquer Diagnostics @ArquerDx]

Manchester University NHS Foundation Trust is taking part in the national MCM5-UTERINE clinical study which aims to evaluate the performance of ADXGYNAE for detecting Endometrial Cancer in women suffering from post-menopausal bleeding.

[Arquer Diagnostics @ArquerDx]

To be eligible for the trial you must have experienced post-menopausal bleeding and be undergoing investigations by a gynaecologist.

[Arquer Diagnostics @ArquerDx]

If you are attending Bedford Hospital for investigation for #postmenopausal bleeding and would like more information, please contact us on [phone]
@EndometrialCanc @IGCSociety @ucan2020 @uterine

[Arquer Diagnostics @ArquerDx]

@ArquerDx
are pleased to announce that Bedford Hospital is taking part in the national MCM5-UTERINE clinical study.

[Arquer Diagnostics @ArquerDx]

To be eligible for the trial you must have experienced #postmenopausal bleeding and be undergoing investigation by a #gynaecologist

[Arquer Diagnostics @ArquerDx]

If you are attending University Hospital of North Durham for investigation for #postmenopausal bleeding and would like more information, please contact us on [phone]

[Arquer Diagnostics @ArquerDx]

@ArquerDx are pleased to announce that University Hospital of North Durham are taking part in the national MCM5-UTERINE clinical study.

[Arquer Diagnostics @ArquerDx]

|To be eligible for the trial you must have experienced #postmenopausal bleeding and be undergoing investigation by a #gynecologist

[Arquer Diagnostics @ArquerDx]

Let's not forget the many pts diagnosed with Bladder Cancer every year and the many Urologists/Associations/Companies focused on making their journey a safe and successful one! We continue to stand with them, every day.

[Arquer Diagnostics @ArquerDx]

If you are attending Scunthorpe General Hospital and Diana Princess of Wales Hospital for investigations for post-menopausal bleeding and would like more information, please contact us on [phone].

[Arquer Diagnostics @ArquerDx]

@ArquerDx are pleased to announce that Scunthorpe General Hospital and Diana Princess of Wales Hospital are taking part in the national MCM5-UTERINE clinical study.

[Arquer Diagnostics @ArquerDx]

To be eligible for the trial you must have experienced #postmenopausal bleeding and be undergoing investigations by a gynaecologist.